Drug Profile
KDI 792
Alternative Names: FK 070; FR 121070Latest Information Update: 12 Oct 2006
Price :
$50
*
At a glance
- Originator Fujisawa
- Developer Fujisawa; Kissei Pharmaceutical
- Class Small molecules
- Mechanism of Action Thromboxane A2 receptor antagonists; Thromboxane A2 synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Cerebrovascular disorders; Diabetic neuropathies; Peripheral vascular disorders
Most Recent Events
- 12 Oct 2006 Discontinued - Clinical-Phase-Unknown for Diabetic neuropathies in Japan (unspecified route)
- 12 Oct 2006 Discontinued - Phase-II for Cerebrovascular disorders in Japan (unspecified route)
- 12 Oct 2006 Discontinued - Phase-II for Peripheral vascular disorders in Japan (unspecified route)